Longeveron, Inc. (LGVN)
2.48
0.00 (0.00%)
USD |
NASDAQ |
Oct 12, 13:54
Longeveron Market Cap : 7.866M for Oct. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 7.866M |
| October 08, 2026 | 7.517M |
| October 07, 2026 | 7.739M |
| October 06, 2026 | 7.454M |
| October 05, 2026 | 7.962M |
| October 02, 2026 | 8.184M |
| October 01, 2026 | 8.215M |
| September 30, 2026 | 8.532M |
| September 29, 2026 | 8.628M |
| September 28, 2026 | 8.342M |
| September 25, 2026 | 8.913M |
| September 24, 2026 | 9.230M |
| September 23, 2026 | 8.247M |
| September 22, 2026 | 8.628M |
| September 21, 2026 | 7.771M |
| September 18, 2026 | 7.898M |
| September 17, 2026 | 8.596M |
| September 16, 2026 | 21.19M |
| September 15, 2026 | 21.76M |
| September 14, 2026 | 21.95M |
| September 11, 2026 | 23.25M |
| September 10, 2026 | 21.06M |
| September 09, 2026 | 20.87M |
| September 08, 2026 | 21.09M |
| September 04, 2026 | 21.60M |
| Date | Value |
|---|---|
| September 03, 2026 | 20.87M |
| September 02, 2026 | 21.51M |
| September 01, 2026 | 21.41M |
| August 31, 2026 | 21.89M |
| August 28, 2026 | 21.32M |
| August 27, 2026 | 21.57M |
| August 26, 2026 | 22.31M |
| August 25, 2026 | 21.57M |
| August 24, 2026 | 26.57M |
| August 21, 2026 | 267.99M |
| August 20, 2026 | 262.69M |
| August 19, 2026 | 260.82M |
| August 18, 2026 | 249.69M |
| August 17, 2026 | 260.09M |
| August 14, 2026 | 234.69M |
| August 13, 2026 | 221.27M |
| August 12, 2026 | 236.91M |
| August 11, 2026 | 219.52M |
| August 10, 2026 | 233.54M |
| August 07, 2026 | 242.96M |
| August 06, 2026 | 245.34M |
| August 05, 2026 | 230.63M |
| August 04, 2026 | 235.38M |
| August 03, 2026 | 232.18M |
| July 31, 2026 | 222.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.546B |
| Oncolytics Biotech, Inc. | 61.08M |
| Sangamo Therapeutics, Inc. | 61.22M |
| Sarepta Therapeutics, Inc. | 1.854B |
| Anixa Biosciences, Inc. | 99.60M |
Market Cap Related Metrics
| PS Ratio | 5.091 |
| Price to Book Value | 0.7562 |
| Price | 2.48 |
| Earnings Yield | -409.3% |